$ENTB Entest BioMedical Inc.'s (ENTB) Zander Therapeutics subsidiary has added Harry Lander, PhD, MBA as its President and Chief Scientific Officer and Todd S. Caven as its Chief Financial Officer. Thomas Ichim, PhD will assist the company as its Senior Scientific Consultant and Debbie Dorsee will serve as Director of Business Development.
http://finance.yahoo.com/news/entest-biomedic...NlYwNzYw--
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!